Evaluating a Vaccine for Leishmaniasis
Researchers will evaluate the efficacy of a vaccine for visceral leishmaniasis, a parasitic disease, in United States foxhounds.
Researchers will evaluate the efficacy of a vaccine for visceral leishmaniasis, a parasitic disease, in United States foxhounds.
Researchers will characterize key elephant immune responses to infection by the elephant endotheliotropic herpesvirus, a virus that causes a devastating hemorrhagic disease in young calves.
Researchers will investigate how immune response cells, called dendritic cells, function and the role they play in the development of life-threatening bacterial infections in foals.
Researchers will evaluate the ability of two agents to improve immune responses against Rhodococcus equi pneumonia in young foals.
Researchers will investigate the effectiveness of the drug misoprostol in treating inflammation in horses.
Researchers will develop a state-of-the-art molecular tool to track and study killer T-cell populations that are responsible for fighting viral infections and cancer in dogs.
Researchers will investigate the development of new therapies to treat devil facial tumor disease, which has already caused an 85 percent decline in the endangered Tasmanian devil population.